Beifang Ning

2.7k total citations
36 papers, 2.2k citations indexed

About

Beifang Ning is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Beifang Ning has authored 36 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Cancer Research and 11 papers in Hepatology. Recurrent topics in Beifang Ning's work include Liver physiology and pathology (11 papers), MicroRNA in disease regulation (10 papers) and Liver Disease Diagnosis and Treatment (7 papers). Beifang Ning is often cited by papers focused on Liver physiology and pathology (11 papers), MicroRNA in disease regulation (10 papers) and Liver Disease Diagnosis and Treatment (7 papers). Beifang Ning collaborates with scholars based in China, United States and Hong Kong. Beifang Ning's co-authors include Jin Ding, Wei‐Fen Xie, Hongyang Wang, Wen Sun, Daimin Xiang, Kun Wu, Junping Zhang, Cheng Chen, Chuan Yin and Xiuliang Cui and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.

In The Last Decade

Beifang Ning

36 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beifang Ning China 23 1.4k 929 509 488 359 36 2.2k
Wenxiu Zhao China 28 1.4k 1.0× 596 0.6× 577 1.1× 239 0.5× 242 0.7× 67 2.4k
Guang‐Zhi Jin China 25 1.2k 0.9× 733 0.8× 380 0.7× 205 0.4× 200 0.6× 48 1.7k
Zhongjun Wu China 24 1000 0.7× 669 0.7× 191 0.4× 336 0.7× 387 1.1× 116 1.8k
Qiudong Zhao China 27 1.2k 0.9× 606 0.7× 739 1.5× 317 0.6× 715 2.0× 49 2.5k
Josefa Castillo Spain 20 946 0.7× 512 0.6× 683 1.3× 352 0.7× 304 0.8× 55 2.1k
Changwei Dou China 22 1.2k 0.9× 852 0.9× 334 0.7× 199 0.4× 198 0.6× 46 1.8k
Guang-Shun Yang China 25 1.5k 1.1× 1.4k 1.5× 385 0.8× 571 1.2× 390 1.1× 50 2.8k
María J. Perugorria Spain 25 1.1k 0.8× 519 0.6× 582 1.1× 610 1.3× 557 1.6× 52 2.6k
Cédric Coulouarn France 30 1.7k 1.3× 1.2k 1.3× 862 1.7× 698 1.4× 410 1.1× 72 3.2k
Ànna Manzano Spain 22 1.2k 0.9× 876 0.9× 263 0.5× 110 0.2× 232 0.6× 41 1.8k

Countries citing papers authored by Beifang Ning

Since Specialization
Citations

This map shows the geographic impact of Beifang Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beifang Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beifang Ning more than expected).

Fields of papers citing papers by Beifang Ning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beifang Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beifang Ning. The network helps show where Beifang Ning may publish in the future.

Co-authorship network of co-authors of Beifang Ning

This figure shows the co-authorship network connecting the top 25 collaborators of Beifang Ning. A scholar is included among the top collaborators of Beifang Ning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beifang Ning. Beifang Ning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ning, Beifang, et al.. (2025). The gut microbiota: an emerging modulator of drug resistance in hepatocellular carcinoma. Gut Microbes. 17(1). 2473504–2473504. 7 indexed citations
2.
Wang, Jian, Beifang Ning, Qi Zhao, et al.. (2022). Sustained ameliorating effects and autonomic mechanisms of transcutaneous electrical acustimulation at ST36 in patients with chronic constipation. Frontiers in Neuroscience. 16. 1038922–1038922. 7 indexed citations
3.
Wang, Yujie, Peng Gao, Chen Ling, et al.. (2022). The effect of neoadjuvant chemotherapy on the tumor immune microenvironment in gastrointestinal tumors. Frontiers in Oncology. 12. 1054598–1054598. 3 indexed citations
4.
Zhou, Tengfei, Shichao Li, Daimin Xiang, et al.. (2020). m6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance. Signal Transduction and Targeted Therapy. 5(1). 296–296. 100 indexed citations
5.
Cheng, Zhuo, Zhiying He, Yongchao Cai, et al.. (2018). Conversion of hepatoma cells to hepatocyte-like cells by defined hepatocyte nuclear factors. Cell Research. 29(2). 124–135. 61 indexed citations
6.
Xiang, Daimin, Wen Sun, Beifang Ning, et al.. (2017). The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis. Gut. 67(9). 1704–1715. 181 indexed citations
7.
Li, Xiaofeng, Cheng Chen, Daimin Xiang, et al.. (2017). Chronic inflammation‐elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance. Hepatology. 66(6). 1934–1951. 104 indexed citations
8.
Wang, Xue, Wen Sun, Weifeng Shen, et al.. (2016). Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis. Journal of Hepatology. 64(6). 1283–1294. 255 indexed citations
9.
Liu, Jiao, Sheng Chen, Wei Wang, et al.. (2016). Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways. Cancer Letters. 379(1). 49–59. 185 indexed citations
10.
Lu, Cuihua, Chen Fei, Wenping Xu, et al.. (2015). MicroRNA-370 Attenuates Hepatic Fibrogenesis by Targeting Smoothened. Digestive Diseases and Sciences. 60(7). 2038–2048. 16 indexed citations
11.
Tang, Nan, Kaiming Wu, Jian Shi, et al.. (2014). MiR-21 Simultaneously Regulates ERK1 Signaling in HSC Activation and Hepatocyte EMT in Hepatic Fibrosis. PLoS ONE. 9(10). e108005–e108005. 94 indexed citations
12.
Ning, Beifang, Jiao Liu, Wenping Xu, et al.. (2014). Abstract 134: HNF4α inhibits liver cancer metastasis via suppression of NF-кB activity. Cancer Research. 74(19_Supplement). 134–134. 1 indexed citations
13.
Xu, Wenping, Min Yi, Qianqian Li, et al.. (2013). Perturbation of MicroRNA-370/Lin-28 homolog A/nuclear factor kappa B regulatory circuit contributes to the development of hepatocellular carcinoma. Hepatology. 58(6). 1977–1991. 62 indexed citations
14.
Wen, Wen, Jin Ding, Wen Sun, et al.. (2012). Cyclin G1–mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase/Akt signaling facilitates liver cancer progression. Hepatology. 55(6). 1787–1798. 91 indexed citations
15.
Sun, Wen, Jin Ding, Kun Wu, et al.. (2011). Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells. Hepatology. 54(4). 1259–1272. 48 indexed citations
16.
Wen, Wen, Jin Ding, Wen Sun, et al.. (2010). Suppression of Cyclin D1 by Hypoxia-Inducible Factor-1 via Direct Mechanism Inhibits the Proliferation and 5-Fluorouracil–Induced Apoptosis of A549 Cells. Cancer Research. 70(5). 2010–2019. 69 indexed citations
17.
Ning, Beifang, Jin Ding, Chuan Yin, et al.. (2010). Hepatocyte Nuclear Factor 4α Suppresses the Development of Hepatocellular Carcinoma. Cancer Research. 70(19). 7640–7651. 194 indexed citations
18.
Song, Chunyan, Xin Zeng, Siwen Chen, et al.. (2010). Sophocarpine alleviates non‐alcoholic steatohepatitis in rats. Journal of Gastroenterology and Hepatology. 26(4). 765–774. 17 indexed citations
19.
Ding, Jin, Beifang Ning, Yi Huang, et al.. (2009). PI3K/Akt/JNK/c-Jun Signaling Pathway is a Mediator for Arsenite- Induced Cyclin D1 Expression and Cell Growth in Human Bronchial Epithelial Cells. Current Cancer Drug Targets. 9(4). 500–509. 28 indexed citations
20.
Ding, Jin, Guoping He, Wenfeng Gong, et al.. (2009). Effects of Nickel on Cyclin Expression, Cell Cycle Progression and Cell Proliferation in Human Pulmonary Cells. Cancer Epidemiology Biomarkers & Prevention. 18(6). 1720–1729. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenxiu Zhao Breakdown of academic impact, for papers by Guang‐Zhi Jin Breakdown of academic impact, for papers by Zhongjun Wu Breakdown of academic impact, for papers by Qiudong Zhao Breakdown of academic impact, for papers by Josefa Castillo Breakdown of academic impact, for papers by Changwei Dou Breakdown of academic impact, for papers by Guang-Shun Yang Breakdown of academic impact, for papers by María J. Perugorria Breakdown of academic impact, for papers by Cédric Coulouarn Breakdown of academic impact, for papers by Ànna Manzano
Rankless by CCL
2026